Dan Jones

As Group Lead for the Vaccine Technology group, I work alongside Professor Dame Sarah Gilbert and her team to help guide the development of existing and emerging vaccine platforms, with the overarching goal of improving technologies for pandemic preparedness.

I joined the PSI after working at Barinthus Biotherapeutics, where I led projects developing novel viral vector–based vaccine platforms. Before that, I contributed to the advancement of the lentiviral platform at Oxford BioMedica.

Before moving into biotech, I completed postdoctoral fellowships at the Centre for Human Genetics (University of Oxford), studying viral entry into host cells, and at Memorial University of Newfoundland, investigating the molecular mechanisms governing hepatitis C virus assembly and release. I obtained my PhD from the University of Glasgow in 2009.